Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced it has released its first-ever Corporate Social Responsibility (CSR) report, Cultivate Impact. The report, which reflects on the past year, highlights local, national and industry initiatives that have made a positive impact specific to the Company’s focus areas: opportunity, inclusion, access and sustainability.

“It is our responsibility as an industry leader to create a mission-driven framework for our company and demonstrate what cannabis and its workforce can do for the world. This report just scratches the surface of how we have strived to do just that,” said Nicholas Vita, CEO and Co-founder, Columbia Care. “I am so proud of the tremendous work our teams have put in across the country to make a difference not only in the cannabis industry but also in the local communities where we operate.”

Columbia Care’s CSR work centers around four key principles: “opportunity”, which focuses on bringing social justice, education and entrepreneurship opportunities to cultivate the inclusive cannabis industry of the future; “inclusion”, which celebrates authenticity and different perspectives that drive the Company and industry forward; “access”, which is a commitment to ending stigmas and ensuring that cannabis is made available to those who need it; and “sustainability”, which creates more sustainable practices through innovation and working with environmentally-responsible partners.

“From social justice to medical accessibility and beyond, we’ve worked diligently from the local neighborhood dispensary level to a multi-state scale to help bring about positive change,” said Ngiste Abebe, VP of Public Policy, Columbia Care. “In addition to our mission-driven employees, we’ve also been really lucky to find strategic partners and vendors who have helped make this work possible. This report is just a start; we look forward to continuing this important work in the future.”

For more information, visit www.columbia.care/about-us/our-impact.

About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 17 U.S. jurisdictions. Columbia Care operates 132 facilities including 99 dispensaries and 33 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.columbia.care.

Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on corporate initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10 dated May 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents filed by the Company with Canadian and U.S. securities regulatory authorities.